In hepatocellular carcinoma (HCC) cells, the overexpression of SIRT6 impairs cancer cell proliferation via the inhibition of ERK1/2 signaling and induces apoptosis by increasing cleaved caspase-3 levels [23]. Here, SIRT6 is linked to hepatocellular carcinoma.